DME Capital Management (Greenlight, David Einhorn) — GANX Trade History
Quarter-by-quarter changes in the GAIN THERAPEUTICS INC position · CUSIP 36269B105
Currently held · 2.5 YearsFirst seen: 2024 Q1
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Hold | 566,130 | — | 0.0% | $1.1M | 0.03% |
| 2026 Q1 | 2026-05-15 | Hold | 566,130 | — | 0.0% | $1.1M | 0.03% |
| 2025 Q4 | 2026-02-17 | Hold | 566,130 | — | 0.0% | $1.8M | 0.06% |
| 2025 Q3 | 2025-11-14 | Hold | 566,130 | — | 0.0% | $1.0M | 0.04% |
| 2025 Q2 | 2025-08-14 | Hold | 566,130 | — | 0.0% | $1.0M | 0.04% |
| 2025 Q1 | 2025-05-15 | Hold | 566,130 | — | 0.0% | $1.1M | 0.06% |
| 2024 Q4 | 2025-02-14 | Hold | 566,130 | — | 0.0% | $1.2M | 0.06% |
| 2024 Q3 | 2024-11-14 | Hold | 566,130 | — | 0.0% | $1.0M | 0.04% |
| 2024 Q2 | 2024-08-14 | Hold | 566,130 | — | 0.0% | $724.6K | 0.04% |
| 2024 Q1 | 2024-05-15 | New | 566,130 | 566,130 | — | $2.1M | 0.10% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.